Form 4: Guardant Health Director Myrtle S. Potter Reports Stock Transactions
SEC Form 4
Director Myrtle S. Potter reports the vesting and conversion of restricted stock units into common stock of Guardant Health, Inc.
Summary
- On February 15, 2025, Director Myrtle S. Potter converted 68 restricted stock units (RSUs) into 68 shares of Guardant Health, Inc. common stock.
- The transaction was executed under transaction code 'M', indicating the exercise or conversion of a derivative security.
- Following the transaction, Potter directly owns 13,858 shares of Guardant Health, Inc. common stock.
- Potter also directly owns 548 derivative securities.
Sentiment
Score: 5
Explanation: This is a neutral report of stock transactions by a company director, with no inherent positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities and ownership positions in the company.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it represents a small number of shares relative to the total outstanding.
Key Dates
| Date | Description |
|---|---|
| October 15, 2022 | 25% of the restricted stock units vested. |
| February 15, 2025 | Conversion of 68 restricted stock units into common stock. |
| February 18, 2025 | Date of signature for the Form 4 filing. |
Keywords
Guardant Health, Director, Stock Transaction, Form 4, Restricted Stock Units, Common Stock, Beneficial Ownership, Myrtle S. Potter
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.